We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EMA Establish Working Group to Incorporate Patients into Drug Development
FDA, EMA Establish Working Group to Incorporate Patients into Drug Development
The FDA and the European Medicines Agency have formed a new working group focusing on incorporating patient perspectives into drug development, evaluation and post-marketing activities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor